Clinical trials
Recurrence trials in Hong Kong
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Active, not recruiting | 4 |
| Terminated | 4 |
| Recruiting | 3 |
| Unknown status | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The University of Hong Kong | 6 |
| Chinese University of Hong Kong | 4 |
| Novartis Pharmaceuticals | 3 |
| Alexion Pharmaceuticals, Inc. | 2 |
| Clovis Oncology, Inc. | 2 |
| Amgen | 1 |
| Astellas Pharma Singapore Pte. Ltd. | 1 |
| AstraZeneca | 1 |
| Bristol-Myers Squibb | 1 |
| Eisai Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 26 |
| Neoplasm Metastasis | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Demyelinating Diseases | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Multiple Myeloma | 2 |
| Myelitis, Transverse | 2 |
| Nasopharyngeal Carcinoma | 2 |
| Nasopharyngeal Neoplasms | 2 |
| Neoplasms | 2 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.